Search Results - "Bromberg, C."
-
1
Improved Limits on Millicharged Particles Using the ArgoNeuT Experiment at Fermilab
Published in Physical review letters (03-04-2020)“…A search for millicharged particles, a simple extension of the standard model, has been performed with the ArgoNeuT detector exposed to the Neutrinos at the…”
Get full text
Journal Article -
2
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Published in Neuro-oncology (Charlottesville, Va.) (05-01-2023)“…The management of primary central nervous system (PCNSL) is one of the most controversial topics in neuro-oncology because of the complexity of the disease and…”
Get full text
Journal Article -
3
Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study
Published in Therapeutic advances in medical oncology (01-06-2019)“…Background: High-grade glioma cells consume mainly glucose and cannot compensate for glucose restriction. Apoptosis may potentially occur under carbohydrate…”
Get full text
Journal Article -
4
Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis
Published in Hematological oncology (01-12-2019)“…The CD‐20 antibody rituximab is a standard component of treatment of non‐Hodgkin B‐cell lymphomas, including diffuse large B‐cell lymphoma (DLBCL). Primary…”
Get full text
Journal Article -
5
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
Published in Cancers (16-04-2021)“…Primary central nervous system lymphoma (PCNSL) is a type of non-Hodgkin lymphoma limited to the central nervous system. It has a poor prognosis. Consensus has…”
Get full text
Journal Article -
6
Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma
Published in Haematologica (Roma) (01-07-2014)“…The benefit of intrathecal therapy and systemic rituximab on the outcome of diffuse large B-cell lymphoma at risk of central nervous system disease is…”
Get full text
Journal Article -
7
First measurements of inclusive muon neutrino charged current differential cross sections on argon
Published in Physical review letters (20-04-2012)“…The ArgoNeuT Collaboration presents the first measurements of inclusive muon neutrino charged current differential cross sections on argon. Obtained in the…”
Get full text
Journal Article -
8
Oligodendrogliomas: Molecular Biology and Treatment
Published in The oncologist (Dayton, Ohio) (01-02-2009)“…Learning Objectives Evaluate the current challenges in the histological diagnosis of oligodendroglial tumors and apply best practices to optimize patient…”
Get full text
Journal Article -
9
Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma
Published in Leukemia & lymphoma (02-09-2017)“…Central nervous system (CNS) involvement in systemic B-cell non-Hodgkin lymphoma (B-NHL) at diagnosis (sysCNS) is rare. We investigated the outcome of 21…”
Get full text
Journal Article -
10
First measurement of neutrino and antineutrino coherent charged pion production on argon
Published in Physical review letters (23-12-2014)“…We report on the first cross section measurements for charged current coherent pion production by neutrinos and antineutrinos on argon. These measurements are…”
Get full text
Journal Article -
11
Primary intracranial germ-cell tumors in adults: a practical review
Published in Journal of neuro-oncology (01-06-2013)“…Primary intracranial germ-cell tumors are rare tumors primarily of adolescence, and literature on this disease in adults is scarce. The available evidence on…”
Get full text
Journal Article -
12
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up
Published in HemaSphere (01-06-2024)“…Highlights This EHA‐ESMO Clinical Practice Guideline provides key recommendations for managing primary DLBCL of the CNS. The guideline covers clinical, imaging…”
Get full text
Journal Article -
13
Flow cytometry shows added value in diagnosing lymphoma in brain biopsies
Published in Cytometry. Part B, Clinical cytometry (01-11-2018)“…Background To assess the sensitivity, specificity and turnaround time of flow cytometric analysis on brain biopsies compared to histology plus…”
Get full text
Journal Article -
14
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response
Published in Neuro-oncology (Charlottesville, Va.) (01-02-2011)“…Only a few studies examined the effect of temozolomide (TMZ) in recurrent low-grade astrocytoma (LGA) after surgery, none of which included a homogeneous and…”
Get full text
Journal Article -
15
Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis
Published in British journal of haematology (01-10-2010)“…Summary Elderly patients with primary central nervous ystem lymphoma (PCNSL) do not tolerate treatment with combined radio‐chemotherapy well because of…”
Get full text
Journal Article -
16
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Published in The lancet oncology (01-08-2014)“…Summary Background Treatment options for recurrent glioblastoma are scarce, with second-line chemotherapy showing only modest activity against the tumour…”
Get full text
Journal Article -
17
-
18
Primary central nervous system lymphoma
Published in Journal of neurology (01-05-2024)“…Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin lymphoma (NHL) manifesting in the brain, spinal cord, cerebrospinal fluid and/or…”
Get full text
Journal Article -
19
Lomustine and Bevacizumab in Progressive Glioblastoma
Published in The New England journal of medicine (16-11-2017)“…The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase…”
Get full text
Journal Article -
20
Is there a future for maintenance temozolomide chemotherapy in PCNSL?
Published in Neuro-oncology (Charlottesville, Va.) (06-04-2023)Get full text
Journal Article